Nasopharyngeal Neoplasms

• CLINICAL_TRIALS trial_result · 2024-04-09
  Clinical Trial Update: PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]

  A Phase 3 trial compares a PD-1 antibody to best supportive care following chemoradiation in locoregionally advanced nasopharyngeal carcinom…

• CLINICAL_TRIALS trial_result · 2023-03-28
  Clinical Trial Update: Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma [Phase 3]

  Phase 3 trial evaluating sintilimab with chemoradiotherapy for locoregionally-advanced nasopharyngeal carcinoma.

• CLINICAL_TRIALS trial_result · 2021-12-15
  Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122) [Phase 3]

  Phase 3 trial of pembrolizumab in platinum-pretreated recurrent/metastatic nasopharyngeal cancer completed with results posted in 2021.

• CLINICAL_TRIALS trial_result · 2019-12-02
  Clinical Trial Update: Intensity Modulated Radiation Therapy for Head and Neck Cancer [Phase 2]

  Phase 2 trial update evaluating intensity-modulated radiation therapy for nasopharyngeal neoplasms.

• CLINICAL_TRIALS research · 2019-01-31
  Clinical Trial Update: A Trial of Endostar in Patients With Carcinoma of the Head and Neck [Phase 2]

  This document notes a Phase 2 trial evaluating Endostar (recombinant human endostatin) in patients with nasopharyngeal neoplasms, with the t…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-10-09
  Clinical Trial Update: PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma [Phase 2]

  Phase 2 trial evaluating PD-1 blockade combined with definitive chemoradiation in locoregionally-advanced nasopharyngeal carcinoma.

• CLINICAL_TRIALS trial_result · 2018-06-01
  Clinical Trial Update: Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma [Phase 2]

  Phase 2 trial evaluating CC-486 in previously treated locally advanced or metastatic nasopharyngeal carcinoma has completed with posted resu…

• CLINICAL_TRIALS research · 2017-07-13
  Clinical Trial Update: A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens [Phase 2]

  Phase II clinical trial comparing effectiveness and safety of different amifostine regimens; the study includes Nasopharyngeal neoplasms, Sa…